Tag Archives: patents

Myriad vs. Mayo – Detection vs. Processing at the Fed. Cir.

Posted on April 26, 2016 by Warren Woessner

Rapid Litigation Mgmt v. CellzDirect: Splitting Detection of a Natural Phenomenon from its Application to Yield a Product. Courtenay G. Brinkerhoff at pharmapatentsblog.com summarized the oral arguments at the Fed. Cir. (App. No. 15-1570) conducted on April 5, 2016 in … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 1 Comment

Superman Breyer v. Batman Lourie Battle in the Sequenom Petition for Cert.

Posted on March 27, 2016 by Warren Woessner

Since this is an amplification of my last post on the Sequenom petition for cert. in Sequenom v. Ariosa, please go back at read my first post on the petition. I have been arguing for some years that the patent … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Sequenom Files Petition for Cert. After Invalidation of Cff Patent

Posted on March 22, 2016 by Warren Woessner

Sequenom, the loser in “Ariosa,” has filed a petition seeking Supreme Court review of the Fed. Cir.’s invalidation of the claims of US Pat. No. 6,258,540 as an attempt to claim a natural product, cffDNA. While there is no dispute … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

Takeaways From Chisum Patent Academy March 2016 Seminar

Posted on March 17, 2016 by Warren Woessner

Takeaways from Our March 2016 Cincinnati Seminar By Donald S. Chisum and Janice M. Mueller Copyright 2016 Chisum Patent Academy, Inc. On March 10-11, 2016 the Chisum Patent Academy held a small-group seminar at the 21C Museum Hotel in Cincinnati, … Continue reading →

Posted in Miscellaneous | Tagged , , , , , , | Leave a comment